Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-02-25 @ 7:22 PM
Study NCT ID:
NCT05201404
Status:
RECRUITING
Last Update Posted:
2025-04-29
First Post:
2021-12-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Sponsor:
Can-Fite BioPharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CF102-301HCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None